SOMESThesia and ALIMentation
Launched by HOSPICES CIVILS DE LYON · Mar 8, 2022
Trial Information
Current as of June 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- All subjects:
- • Person between 18 and 65 years
- • Person having given free, informed, express written consent
- • Person affiliated to a French social security system
- • Person with a body mass superior to 18 kg/m².
- • Person able to come once to the Institut Paul Bocuse
- Patients with head and neck cancer with chemotherapy:
- • - Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone
- Patients with head and neck cancer without chemotherapy:
- • - Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone
- Healthy volunteers :
- • Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
- • Volunteer of the same sex as the patient to whom they are matched
- • Volunteer with the same smoking status as the patient to whom they are matched
- • Volunteer who has not had cancer within 5 years at the time of inclusion
- • Volunteer with no current treatment that may affect taste and smell perception
- Exclusion Criteria:
- All subjects:
- • Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
- • Person with a known allergy to chili (or capsaicin)
- • Person with diagnosed total ageusia
- • Person with diagnosed total anosmia
- • Person who has used artificial feeding within 2 months prior to inclusion.
- • Person who has lost more than 10% of baseline weight in the 2 months prior to inclusion
- • Person deprived of liberty or under guardianship or trusteeship.
- • Pregnant or breastfeeding woman
- • Person deprived of liberty by a judicial or administrative decision
- • Person under guardianship or protection of vulnerable adults
- • Person with trismus (reduced jaw opening or limited jaw range of motion)
- • A person who is unable to extend his or her tongue
- • Person who has had surgery on the mobile tongue and/or base of the tongue
- • Person unable to swallow soft foods
- • Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.
- Patients with head and neck cancer:
- • Patient receiving immunotherapy
- • Patient treated with surgery only.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
écully, , France
Patients applied
Trial Officials
Amandine BRUYAS
Principal Investigator
Hospices Civils de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials